CLYM

Climb Bio, Inc. Common Stock

19 hedge funds and large institutions have $48.4M invested in Climb Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
7
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$38.1M 13,150,849
BCM
2
BML Capital Management
Indiana
$4.81M 1,658,170 -166,964 -9%
DCM
3
Driehaus Capital Management
Illinois
$1.95M 673,684 +121,742 +22%
SCM
4
Silverarc Capital Management
Massachusetts
$1.41M 485,955 +76,753 +19%
Vanguard Group
5
Vanguard Group
Pennsylvania
$796K 274,517
AI
6
Atom Investors
Texas
$229K 78,886 +3,235 +4%
Millennium Management
7
Millennium Management
New York
$196K 67,621 -64 -0.1%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$186K 64,014
Morgan Stanley
9
Morgan Stanley
New York
$181K 62,316 +62,171 +42,877%
BCM
10
Bridgeway Capital Management
Texas
$160K 55,223
BlackRock
11
BlackRock
New York
$94.8K 32,701 +498 +2%
Tudor Investment Corp
12
Tudor Investment Corp
Connecticut
$86K 29,706 -901 -3%
State Street
13
State Street
Massachusetts
$57.4K 19,800
CPIG
14
Chicago Partners Investment Group
Illinois
$52.4K 18,520 +341 +2%
Stifel Financial
15
Stifel Financial
Missouri
$43.1K 14,862
Northern Trust
16
Northern Trust
Illinois
$32.6K 11,247 -247 -2%
TRCT
17
Tower Research Capital (TRC)
New York
$9K 3,262 +2,620 +408%
Bank of America
18
Bank of America
North Carolina
$2.02K 695 -4 -0.6%
Wells Fargo
19
Wells Fargo
California
$122 42
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
-25,244 Closed
CFGS
21
Concourse Financial Group Securities
Alabama